miR-302b inhibits tumorigenesis by targeting EphA2 via Wnt/ β-catenin/EMT signaling cascade in gastric cancer

• Published in: BMC cancer 2017-12, Vol.17 (1), p.886-12, Article 886
• Main Authors: Huang, Jin, He, Yijing, Mcleod, Howard L, Xie, Yanchun, Xiao, Desheng, Hu, Huabin, Chen, Pan, Shen, Liangfang, Zeng, Shan, Yin, Xianli, Ge, Jie, Li, Li, Tang, Lanhua, Ma, Jian, Chen, Zihua
• Format: Article
• Language: English
• Subjects: Analysis; Cancer; Cellular signal transduction; Development and progression; EphA2; Epithelial-mesenchymal transition; Gastric cancer; Genetic aspects; Metastasis; MicroRNA; miR-302b; Stem cells; Stomach cancer; Wnt/β-catenin
• ISSN: 1471-2407; 1471-2407
• DOI: 10.1186/s12885-017-3875-3

EphA2 is a crucial oncogene in gastric cancer (GC) development and metastasis, this study aims to identify microRNAs that target it and serve as key regulators of gastric carcinogenesis. We identified several potential microRNAs targeting EphA2 by bioinformatics websites and then analyzed the role of miR-302b in modulating EphA2 in vitro and in vivo of GC, and it's mechanism. Our analysis identified miR-302b, a novel regulator of EphA2, as one of the most significantly downregulated microRNA (miRNA) in GC tissues. Overexpression of miR-302b impaired GC cell migratory and invasive properties robustly and suppressed cell proliferation by arresting cells at G0-G1 phase in vitro. miR-302b exhibited anti-tumor activity by reversing EphA2 regulation, which relayed a signaling transduction cascade that attenuated the functions of N-cadherin, β-catenin, and Snail (markers of Wnt/β-catenin and epithelial-mesenchymal transition, EMT). This modulation of EphA2 also had distinct effects on cell proliferation and migration in GC in vivo. miR-302b serves as a critical suppressor of GC cell tumorigenesis and metastasis by targeting the EphA2/Wnt/β-catenin/EMT pathway.